首页> 外文OA文献 >Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors

【2h】

Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在靶肿瘤病变中达到相关的生长抑素受体饱和度？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Amir Sabet; James Nagarajah; Ahmet Dogan; Hans-Jürgen Biersack; Amin Sabet; Stefan Guhlke; Samer Ezziddin;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [J] . Amir Sabet, James Nagarajah, Ahmet Semih Dogan, EJNMMI Research . 2013,第1期

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在目标肿瘤病变中达到相关的生长抑素受体饱和度？：转移性胃肠内胰腺神经内分泌肿瘤患者治疗中受体影像的见解
2. Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [J] . Amir Sabet, James Nagarajah, Ahmet S Dogan, EJNMMI Research . 2013,第1期

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在目标肿瘤病变中达到相关的生长抑素受体饱和度？：转移性胃肠内胰腺神经内分泌肿瘤患者治疗中受体成像的见解
3. Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors [J] . Wang Yuhong, Wang Wei, Jin Kaizhou, Oncology letters . 2017,第3aPta1期

机译：Somatostatin受体表达表明胃肠内科神经内分泌肿瘤的预后改善，奥雷德雷德长效释放在中国晚期的胃肠内科神经内分泌肿瘤患者中是有效和安全的
4. ~(213)Bi-DOTATOC receptor targeted alpha-radionuclide therapy induces remission in neuroendocrine tumors refractory to beta-radiation - a first in human study [C] . Giesel FL, Kratochwil C, Bruchertseifer F, 8th International Conference on Isotopes 2014 . 2014

机译：〜（213）Bi-DOTATOC受体靶向的α-放射性核素疗法可诱导难于β辐射的神经内分泌肿瘤缓解-这是人类研究中的首次
5. Upregulation of Somatostatin Receptor 2 in Neuroendocrine Tumors Using Histone Deacetylase Inhibitors [D] . Guenter, Rachael. 2021

机译：用组蛋白脱乙酰酶抑制剂对神经内分泌肿瘤进行生长抑素受体2的上调
6. Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [O] . Amir Sabet, James Nagarajah, Ahmet Semih Dogan, 2013

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在目标肿瘤病变中实现相关的生长抑素受体饱和度？
7. Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors [O] . Yuhong Wang, Wei Wang, Kaizhou Jin, 2017

机译：生长抑素受体表达表明，胃肠内科神经内分泌肿瘤的预后改善，奥德雷德雷德长效释放在中国晚期的胃肠细胞神经内分泌肿瘤患者中是有效和安全的

Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors

著录项

引文网络

相似文献

相关主题

期刊订阅